Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Study: HPV May be the Cause of 1 in 3 Throat Cancer Cases; polyDNA Recommends Gene-Eden-VIR against the Latent HPV

July 24, 2013

A new study, published in the Journal of Clinical Oncology on June 17, 2013 showed that 33% of all throat cancer cases may be caused by HPV infection. (1) polyDNA recommends Gene-Eden-VIR, a natural antiviral supplement, against the latent HPV.

Rochester, NY (PRWEB) July 24, 2013

HPV is a much more common cause of throat cancer than originally thought, and it is spreading. Last month, actor Michael Douglas made headlines when he “told a British newspaper that his throat cancer had come from performing oral sex.” (The New York Times, July 18, 2013) (2) Recent research reports many cases like that of Michael Douglas.

The study from the Journal of Clinical Oncology lasted for ten years. The authors looked at the most common types of cancer-causing HPV strains and their link to throat cancer. The assembled a group of about 1600 healthy individuals and then tested for the presence of HPV twice, at the beginning and the end of the ten year period.

The test at the beginning of the ten year period showed no HPV in any of the patients. The second test, at the end of the ten years, found that 35% of the 135 participants who developed throat cancer had HPV markers. In contrast, in those who didn’t develop cancer, less than one percent showed the HPV markers.

"These striking results provide some evidence that HPV-16 infection may be a significant cause of oropharyngeal cancer." (Dr. Ruth Travis, MedicalDaily.com, July 21, 2013) (3)

“HPV is passed on through genital contact, most often during vaginal and anal sex, but can also be transmitted through oral sex as well. While many HPV infections resolve without treatment within two years, a small percentage of infections can cause more severe health problems, including recurrent respiratory papillomatosis (RRP), a condition in which warts grow in the throat, and a head and neck cancer called oropharyngeal cancer, which develops in the back of the throat, at the base of the tongue, and on the tonsils.” (MedicalDaily.com) (3)

“It’s pretty staggering that a third of throat cancer cases are most likely caused by HPV. Everybody knows that HPV causes cervical cancer. Now, it seems that it’s also a major cause of throat cancer. ” –Mike Evans, polyDNA

polyDNA recommends that people with HP should consider using Gene-Eden-VIR, a natural HPV remedy that is safe and effective according to a post marketing clinical study. (4)

Gene-Eden-VIR is effective against the latent HPV virus, each ingredient was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent form of HPV. (4)

To learn more about Gene-Eden-VIR and HPV, visit http://gene-eden-kill-virus.com/HPV-Remedy.php.

References:

(1)    http://www.ncbi.nlm.nih.gov/pubmed/23775966

(2)    http://www.nytimes.com/2013/07/19/health/hpv-vaccine-found-to-help-with-cancers-of-throat.html

(3)    http://www.medicaldaily.com/articles/17626/20130721/hpv-vaccine-throat-cancer-head-and-neck-cancer-human-papilloma.htm

(4)    http://www.cbcd.net/Gene-Eden-VIR-Clinical-Study.php

(5)    http://gene-eden-kill-virus.com/studies.php

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/7/prweb10949996.htm


Source: prweb